LINC00639

Across TCGA pan-cancer cohorts, LINC00639 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC00639 data layer compared with 1 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC00639 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC00639 expression acts as an unfavorable survival marker, although some lineages such as LUAD and PAAD show a favorable association.

LUAD, PAAD, and HNSC are the cancer types where LINC00639 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.458	0.294	<.001	108	view →
PAAD	DFS	Tertile	All	0.425	0.250	.004	47	view →
HNSC	OS	Tertile	III,IV	0.481	0.259	.001	45	view →
SKCM	OS	Quartile	II,III,IV	0.814	0.637	.001	39	view →
BRCA	OS	Median	III,IV	0.622	0.444	.003	33	view →
THYM	DFS	Tertile	All	0.626	1.000	.005	25	view →
ESCA	OS	Tertile	IV	0.219	0.856	.024	24	view →
BLCA	OS	Median	IV	0.141	0.441	.005	24	view →
KIRC	DFS	Tertile	All	0.927	0.823	.009	20	view →
MESO	OS	Quartile	II,III,IV	0.675	0.420	.018	18	view →
SARC	DFS	Tertile	All	0.682	0.510	.004	18	view →
LUSC	OS	Median	IV	0.057	0.786	.008	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC00639–LUAD (OS)

Open the LUAD breakdown →